⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Official Title: Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm With Micropapillary and Solid Subtype Negative by Intraoperative Frozen Sections: A Prospective and Multi-center Randomized Controlled Trial Study

Study ID: NCT04937283

Study Description

Brief Summary: This study aims to evaluate the non-inferiority in recurrence-free survival and overall survival of segmentectomy compared with lobectomy in patients with lung adenocarcinoma ≤ 2 cm with micropapillary and solid subtype negative by intraoperative frozen sections.

Detailed Description: At present, the technology of intraoperative frozen section has gradually matured, which can diagnose the benign and malignant tumors and guide the resection strategy for peripheral small-sized lung adenocarcinoma. Travis et al. reported high specificity of intraoperative frozen section in the identification of micropapillary components, confirming that intraoperative frozen section may guide the selection of surgical procedures. However, there is still little evidence weather segmentectomy is appropriate for invasive adenocarcinoma without micropapillary patterns. This prospective and multi-center study was aimed to evaluate the non-inferiority in recurrence free survival and overall survival of segmentectomy compared with lobectomy in patients with lung adenocarcinoma (≤ 2 cm) not including micropapillary components.

Keywords

Eligibility

Minimum Age: 20 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Anhui Chest Hospital, Hefei, Anhui, China

The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, China

Nanyang Central Hospital, Nanyang, Henan, China

The Sixth People's Hospital of Nantong, Nantong, Jiangsu, China

Affiliated Hospital of Nantong University, Nantong, Jiangsu, China

Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China

Yancheng First People's Hospital, Yancheng, Jiangsu, China

Shandong Public Health Clinical Center, Jinan, Shandong, China

Shanghai Pulmonary Hospital, Shanghai, Shanghai, China

Huadong Hospital, Shanghai, Shanghai, China

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Huzhou Central Hospital, Huzhou, Zhejiang, China

Ningbo First Hospital, Ningbo, Zhejiang, China

Ningbo No.2 Hospital, Ningbo, Zhejiang, China

Contact Details

Name: Chang Chen, MD, PhD

Affiliation: Shanghai Pulmonary Hospital, School of Medicine, Tongji University

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: